Tower Wealth Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Tower Wealth Partners's MRK Position: Q2 2026 in Review
Tower Wealth Partners increased its Merck (MRK) stake by 3.5% in Q2 2026, buying an estimated $18.6K and bringing the position to 4,683 shares worth $602K. The position accounts for 0.3% of the portfolio, ranked #38.
Tower Wealth Partners first reported a position in MRK in Q4 2020 and has held it in 23 quarters since. The position peaked at $976K in Q2 2024. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Tower Wealth Partners held 4,683 shares of Merck worth $602K as of Q2 2026.
- Tower Wealth Partners bought 159 Merck shares in Q2 2026, an estimated $18.6K.
- Merck made up 0.3% of Tower Wealth Partners's portfolio in Q2 2026, its #38 holding.
- Tower Wealth Partners first reported a position in Merck in Q4 2020 and has held it in 23 quarters since.
- Tower Wealth Partners's Merck position peaked at $976K in Q2 2024.
- 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Tower Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.